News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.
Featured News Item
A year of discovery: Looking back at 2025 and ahead to 2026
In 2025, RECOVER’s progress included closing the first phase of its adult observational study and publishing its first clinical trial results. This year, the initiative continues its studies and sharing research findings.
Feature
17 Results
17 Results
Over 1.4 million biosamples available in RECOVER’s biorepository to support Long COVID research
Biostatisticians and clinicians work together to help funded study teams access resources stored in RECOVER’s biorepository, a unique collection of biosamples from almost 30,000 adults and children.
Feature
RECOVER biosamples and data advance understanding of what may cause Long COVID
RECOVER pathobiologists have designed a large, collaborative, and innovative study that can help to develop diagnostics for specific types of Long COVID.
Feature
Registration open for second annual RECOVER-TLC workshop, September 9-10
NIH leaders and RECOVER researchers will provide updates on RECOVER-Treating Long COVID (RECOVER-TLC), the next phase of RECOVER Long COVID clinical trials.
Announcement
Researchers invited to submit proposals for new round of ancillary pathobiology studies
RECOVER released a call for ancillary pathobiology study proposals that will build on the more than 60 existing funded studies and will address unanswered questions about Long COVID.
Feature
RECOVER’s mid-year milestones: A look at 2025 progress
This year, RECOVER researchers continue to publish results from research studies that deepen our understanding of Long COVID. RECOVER studies continue, with 2 clinical trials expected to reach enrollment goals this summer.
Feature
RECOVER pathobiology studies look inside the body to learn more about Long COVID
RECOVER is funding 60+ pathobiology studies to explore how cells in the body interact with each other to cause Long COVID symptoms. These findings may lead to better ways to diagnose, treat, and prevent Long COVID.
Feature
Collaborating to advance Long COVID research: RECOVER researchers team up across the Pacific Northwest
Five RECOVER study sites across the Pacific Northwest teamed up to form a consortium. Consortium members learn from other RECOVER researchers’ findings and share knowledge with the community.
Feature
R3 Seminar Recap: Persistent SARS-CoV-2 antigens and correlation with Long COVID symptoms: Findings from a multi-cohort study
During the December 10th RECOVER Research Review (R3) Seminar, researchers described a recent pathobiology study investigating viral persistence, or when SARS-CoV-2 remains in a person’s body and continues to cause changes even after they recover from their initial sickness. The study’s findings suggest that viral persistence could be one reason why some people experience certain symptoms of Long COVID.
R3 Seminar Recap